Valeant to be led by group of senior execs as CEO on medical leave

Mon Dec 28, 2015 8:24am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Dec 28 (Reuters) - Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.

Pearson will be on a medical leave of absence, effective immediately, the company said in a statement on Monday.

Pearson was hospitalized with a "severe case of pneumonia" on Friday and is receiving treatment, a company spokeswoman said on Friday.

Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial officer Robert Rosiello. (Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)